You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥集團指滅活疫苗對全球毒株均有廣泛保護作用
阿思達克 01-20 16:29
國藥集團中國生物副總裁張雲濤表示,從中國生物獲得的數據來看,滅活疫苗有廣譜的保護性,對於全球的毒株都有廣泛的保護作用。

他指出,疫苗從研發到附條件上市以來,對全球新冠病毒變異一直是持續關注的問題之一,去年4月份獲得臨床批件之際就把當時收集到的全球不同來源的毒株用當時的動物血清做了交叉分析免疫原性的研究工作。

他又指,從獲得的數據來看,滅活疫苗有廣譜的保護性,對於全球的毒株都有廣泛的保護作用,觀察到包括南非、英國、尼日利亞發現一些新的新冠病毒的變種,持續的在關注這一變化。中國生物已經開展了實驗室的相關交叉中和試驗的檢測工作,這個檢測工作正在持續的開展過程之中,後續中國生物會密切關注全球新冠病毒的變異情況,做好科研攻關工作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account